180 related articles for article (PubMed ID: 11344984)
1. HIV in the female genital tract: viral shedding and mucosal immunity.
al-Harthi L; Landay A
Clin Obstet Gynecol; 2001 Jun; 44(2):144-53. PubMed ID: 11344984
[No Abstract] [Full Text] [Related]
2. Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract.
Rebbapragada A; Wachihi C; Pettengell C; Sunderji S; Huibner S; Jaoko W; Ball B; Fowke K; Mazzulli T; Plummer FA; Kaul R
AIDS; 2007 Mar; 21(5):589-98. PubMed ID: 17314521
[TBL] [Abstract][Full Text] [Related]
3. HIV infection of the genital mucosa in women.
Hladik F; Hope TJ
Curr HIV/AIDS Rep; 2009 Feb; 6(1):20-8. PubMed ID: 19149993
[TBL] [Abstract][Full Text] [Related]
4. Systemic and mucosal differences in HIV burden, immune, and therapeutic responses.
Wahl SM; Redford M; Christensen S; Mack W; Cohn J; Janoff EN; Mestecky J; Jenson HB; Navazesh M; Cohen M; Reichelderfer P; Kovacs A;
J Acquir Immune Defic Syndr; 2011 Apr; 56(5):401-11. PubMed ID: 21239996
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of mucosal immunity at the female reproductive tract involved in defense against HIV infection.
Choi MW; Isidoro CA; Gillgrass A
Curr Opin Virol; 2024 Jun; 66():101398. PubMed ID: 38484474
[TBL] [Abstract][Full Text] [Related]
6. Regulation of mucosal immunity in the female reproductive tract: the role of sex hormones in immune protection against sexually transmitted pathogens.
Wira CR; Fahey JV; Rodriguez-Garcia M; Shen Z; Patel MV
Am J Reprod Immunol; 2014 Aug; 72(2):236-58. PubMed ID: 24734774
[TBL] [Abstract][Full Text] [Related]
7. Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load.
Cu-Uvin S; Caliendo AM
AIDS; 2011 Mar; 25(6):880-1. PubMed ID: 21412068
[No Abstract] [Full Text] [Related]
8. Anatomic and hormonal changes in the female reproductive tract immune environment during the life cycle: implications for HIV/STI prevention research.
Venkatesh KK; Cu-Uvin S
Am J Reprod Immunol; 2014 Jun; 71(6):495-504. PubMed ID: 24832617
[TBL] [Abstract][Full Text] [Related]
9. Mucosal correlates of protection in HIV-1-exposed sero-negative persons.
Shen R; Smith PD
Am J Reprod Immunol; 2014 Aug; 72(2):219-27. PubMed ID: 24428610
[TBL] [Abstract][Full Text] [Related]
10. Cyclic changes in HIV shedding from the female genital tract during the menstrual cycle.
Curlin ME; Leelawiwat W; Dunne EF; Chonwattana W; Mock PA; Mueanpai F; Thep-Amnuay S; Whitehead SJ; McNicholl JM
J Infect Dis; 2013 May; 207(10):1616-20. PubMed ID: 23417658
[TBL] [Abstract][Full Text] [Related]
11. Localized cyclical variations in immunoproteins in the female genital tract and the implications on the design and assessment of mucosal infection and therapies.
Makinde J; Jones C; Bartolf A; Sibeko S; Baden S; Cosgrove C; Shattock RJ
Am J Reprod Immunol; 2018 Feb; 79(2):. PubMed ID: 29286179
[TBL] [Abstract][Full Text] [Related]
12. Induction of innate immune responses in the female genital tract: friend or foe of HIV-1 infection?
Firoz Mian M; Ashkar AA
Am J Reprod Immunol; 2011 Mar; 65(3):344-51. PubMed ID: 21223417
[TBL] [Abstract][Full Text] [Related]
13. The role of serpin and cystatin antiproteases in mucosal innate immunity and their defense against HIV.
Aboud L; Ball TB; Tjernlund A; Burgener A
Am J Reprod Immunol; 2014 Jan; 71(1):12-23. PubMed ID: 24325760
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 shedding in genital tract of infected women.
Burkhart CN
Lancet; 2002 Apr; 359(9316):1526. PubMed ID: 11988284
[No Abstract] [Full Text] [Related]
15. Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. WHS 001 Study Team.
Reichelderfer PS; Coombs RW; Wright DJ; Cohn J; Burns DN; Cu-Uvin S; Baron PA; Coheng MH; Landay AL; Beckner SK; Lewis SR; Kovacs AA
AIDS; 2000 Sep; 14(14):2101-7. PubMed ID: 11061650
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 shedding in genital tract of infected women.
Fiore JR; Suligoi B; Monno L; Angarano G; Pastore G
Lancet; 2002 Apr; 359(9316):1525-6. PubMed ID: 11988283
[No Abstract] [Full Text] [Related]
17. Effect of the menstrual cycle on virological parameters.
Cu-Uvin S
J Acquir Immune Defic Syndr; 2005 Mar; 38 Suppl 1():S33-4. PubMed ID: 15867614
[No Abstract] [Full Text] [Related]
18. HIV-1 gp120 induces TLR2- and TLR4-mediated innate immune activation in human female genital epithelium.
Nazli A; Kafka JK; Ferreira VH; Anipindi V; Mueller K; Osborne BJ; Dizzell S; Chauvin S; Mian MF; Ouellet M; Tremblay MJ; Mossman KL; Ashkar AA; Kovacs C; Bowdish DM; Snider DP; Kaul R; Kaushic C
J Immunol; 2013 Oct; 191(8):4246-58. PubMed ID: 24043886
[TBL] [Abstract][Full Text] [Related]
19. Cellular superspreaders: an epidemiological perspective on HIV infection inside the body.
Talbert-Slagle K; Atkins KE; Yan KK; Khurana E; Gerstein M; Bradley EH; Berg D; Galvani AP; Townsend JP
PLoS Pathog; 2014 May; 10(5):e1004092. PubMed ID: 24811311
[No Abstract] [Full Text] [Related]
20. Novel Role for Interleukin-17 in Enhancing Type 1 Helper T Cell Immunity in the Female Genital Tract following Mucosal Herpes Simplex Virus 2 Vaccination.
Bagri P; Anipindi VC; Nguyen PV; Vitali D; Stämpfli MR; Kaushic C
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
